Comparative study of the efficacy of transdermal buprenorphine patches and prolonged-release tramadol tablets for postoperative pain control after spinal fusion surgery: a prospective, randomized controlled non-inferiority trial.

Autor:	Kim, Ho-Joong, Ahn, Hyo, Nam, Yunjin, Chang, Bong-Soon, Lee, Choon-Ki, Yeom, Jin, Ahn, Hyo Sae, Yeom, Jin S
Předmět:	BUPRENORPHINE POSTOPERATIVE pain SPINAL fusion TRAMADOL RANDOMIZED controlled trials COMPARATIVE studies DRUG administration LONGITUDINAL method RESEARCH methodology MEDICAL cooperation RESEARCH DRUG tablets TRANSDERMAL medication EVALUATION research PAIN measurement TREATMENT effectiveness THERAPEUTICS
Zdroj:	European Spine Journal; Nov2017, Vol. 26 Issue 11, p2961-2968, 8p
Abstrakt:	Purpose: To compare the efficacy of a transdermal buprenorphine patch (5, 10, 15, and 20 μg/h) with that of oral tramadol (150, 200, 250, and 300 mg) for postoperative pain control after single level spinal fusion surgery.Methods: The present study (ClinicalTrials.gov, number NCT02416804) was a prospective, randomized controlled non-inferiority trial designed to determine the efficacy of buprenorphine TDS for alleviating postoperative pain following patient controlled analgesia (PCA) in persons underwent a single level posterior lumbar interbody fusion surgery through 1:1 allocation. The primary outcome was the Visual Analog Pain Scale (VAS) score for postoperative back pain at 7 days after surgery. The non-inferior margin of the VAS was set at δ = 1.5 points.Results: The VAS score (primary outcome) for postoperative back pain at 7 days after surgery in the Buprenorphine group was not inferior compared to the Tramadol group. The overall changes in VAS scores for postoperative pain during follow-up assessments over a 2-week period did not differ between both groups. However, the VAS scores for postoperative pain significantly improved with time after surgery in both groups. The patterns of changes in the VAS scores for postoperative pain during the follow-up period were not significantly different between the both groups.Conclusions: The efficacy of buprenorphine TDS was not inferior to that of oral tramadol medication for alleviating postoperative pain in the subacute period from 72 h after surgery, following PCA administration. In addition, adverse events were similar between both groups. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink